Bulletin
Investor Alert

Pacira BioSciences Inc.

NAS: PCRX

GO
/marketstate/country/us

After Hours

/zigman2/quotes/202929053/composite

$

52.53

Change

0.00 0.00%

Volume

Volume 7,175

Dec 3, 2021, 6:03 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/202929053/composite

Previous close

$ 53.75

$ 52.53

Change

-1.22 -2.27%

Day low

Day high

$52.11

$54.94

Open
Open: 54.21

52 week low

52 week high

$45.05

$80.00

Open

Market cap

$2.34B

Average volume

514,624

P/E ratio

38.71

Rev. per Employee

$688,537

EPS

1.36

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/pcrx

MarketWatch News on PCRX

  1. Pacira Biosciences to acquire Flexion Therapeutics for $8.50 a share in cash, pulse CVR worth up to $8 a share

    6:03 a.m. Oct. 11, 2021

    - Ciara Linnane

  2. Flexion shares soar 39% premarket

    6:04 a.m. Oct. 11, 2021

    - Ciara Linnane

  3. Tax Time Is Coming. How Stocks With Losses Offset Capital Gains.

    8:03 p.m. Oct. 10, 2021

    - Barron's Online

  4. Pacira BioSciences upgraded to overweight from neutral at J.P. Morgan

    6:54 a.m. July 26, 2021

    - Tomi Kilgore

  5. Biotech stocks are a buy — especially these 18 picks

    1:02 p.m. March 13, 2021

    - Michael Brush

  6. Pacira BioSciences started at buy with $60 stock price target at SunTrust RH

    7:33 a.m. Jan. 24, 2020

    - Tomi Kilgore

  7. Sachem Head Capital Says A Split-Up Eagle Will Fly

    8:30 p.m. July 12, 2019

    - Barron's Online

  8. Pacira Pharmaceuticals reiterated as sell at Stifel

    7:36 a.m. March 8, 2019

    - Ciara Linnane

  9. Resolute’s Resolve

    7:00 p.m. Oct. 26, 2018

    - Barron's Online

  10. Pacira Pharmaceuticals started at neutral with $47 stock price target at J.P. Morgan

    8:12 a.m. Dec. 18, 2017

    - Tomi Kilgore

  11. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/pcrx

Other News on PCRX

  1. 10-Q: PACIRA BIOSCIENCES, INC.

    3:45 p.m. Nov. 3, 2021

    - Edgar Online - (EDG = 10Q, 10K)

  2. Pacira (PCRX) Beats Q3 Earnings Estimates

    9:15 a.m. Nov. 3, 2021

    - Zacks.com

  3. Pacira BioSciences EPS beats by $0.07, misses on revenue

    8:11 a.m. Nov. 3, 2021

    - Seeking Alpha

  4. Notable earnings before Wednesday's open

    11:20 a.m. Nov. 2, 2021

    - Seeking Alpha

  5. Pacira BioSciences Q3 2021 Earnings Preview

    10:26 a.m. Nov. 2, 2021

    - Seeking Alpha

  6. Flexion Therapeutics: Bullish On The Buyout

    9:24 a.m. Oct. 23, 2021

    - Seeking Alpha

  7. Why Pacira Biosciences Stock Sank Today

    3:56 p.m. Oct. 4, 2021

    - Motley Fool

  8. Loading more headlines...
/news/pressrelease/company/us/pcrx

Press Releases on PCRX

  1. Pacira Files Lawsuit Against eVenus for Patent Infringement

    4:44 p.m. Nov. 8, 2021

    - GlobeNewswire

  2. ImmuneID Appoints Veteran Biotech Executive James S. Scibetta as CEO

    7:00 a.m. Sept. 21, 2021

    - BusinessWire - BZX

  3. Loading more headlines...

Rates »

Trending Tickers
  • /zigman2/quotes/200467500/composite NVDA+6.01%
  • /zigman2/quotes/200164174/composite SNOA+85.40%
  • /zigman2/quotes/202092269/composite ENSC+35.46%
  • /zigman2/quotes/226465160/composite ALF-14.72%
  • /zigman2/quotes/207732364/composite MSFT+1.66%
X
Powered by StockTwits
Link to MarketWatch's Slice.